ACAD · Acadia Pharmaceuticals Inc · Documents
$20.31
+0.12 (+0.59%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$3.49B
Shares
172.31M
Volume · Oct 22
1.23M
Avg daily vol (3M)
1.86M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| S-3ASR | — | 2020-08-25 | — | |
| 8-K | — | 2020-08-25 | 2020-08-24 | |
| 8-K | — | 2020-08-06 | 2020-08-05 | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-08-05 | — | |
| 8-K | — | 2020-07-20 | — | |
| 8-K | — | 2020-06-29 | 2020-06-23 | |
| 10-Q | — | 2020-05-08 | 2020-03-31 | |
| 8-K | — | 2020-05-07 | — | |
| DEF 14A | — | 2020-04-29 | 2020-06-23 | |
| 10-K | — | 2020-02-27 | 2019-12-31 | |
| 8-K | — | 2020-02-27 | 2020-02-26 | |
| 8-K | — | 2020-01-13 | — |
Showing 101–113 of 113 filings
Key facts
CIK
1070494
CUSIP
004225108
13F (30d)
42 filings
41 filers
Visit website
Investor relations